Results 311 to 320 of about 2,503,709 (341)

Long-term compromised immune regulation after rituximab induction in blood group incompatible (ABOi) living-donor renal transplantation - 5 year results of a prospective pilot study. [PDF]

Front Immunol
Weimer R, Karakizlis H, Renner F, Dietrich H, Daniel V, Süsal C, Schüttler C, Kämper D, Leicht D, Wörlen M, Milchsack K, Renner L, Stich M, Gröne HJ, Hecker A, Hörbelt R, Padberg W, Opelz G.   +17 more
europepmc   +1 more source

Transplantation and other aspects of surgery of the liver [PDF]

, 1984
Iwatsuki, S, Shaw, BW, Starzl, TE, Van Thiel, DH   +3 more
core  

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Ureteric Complications and Urinary Tract Reconstruction Techniques in Renal Transplantation: A Surgical Essay. [PDF]

J Clin Med
Novacescu D, Abol-Enein H, Latcu S, Zara F, Secasan CC, Barbos V, Pasecinic V, Musta M, Albarakaty AM, Bakhsh A, Ismail H, Cumpanas AA.   +11 more
europepmc   +1 more source

Chimerism after whole organ transplantation: an explanation of renal and other organ acceptance [PDF]

, 1997
Demetris, AJ, Murase, N, Rao, AS, Starzl, TE, Thomson, AW, Trucco, M   +5 more
core  

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Understanding HLA-DQ in renal transplantation: a mini-review. [PDF]

Front Immunol
Das R, Greenspan NS.
europepmc   +1 more source

Enhanced Recovery After Surgery (ERAS) in Renal Transplantation Patients. [PDF]

Turk J Anaesthesiol Reanim
Karaaslan P, Uludağ Yanaral T.
europepmc   +1 more source

Sevoflurane-Associated Acute Liver Injury in Renal Transplantation and Review of Literature. [PDF]

Case Rep Anesthesiol
Gani I, Moin N, Fallah J, Mirza A.
europepmc   +1 more source